You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
High-specificity affinity reagents for N-glycosylation site mapping and glycomics
SBC: GLYCOSENSORS AND DIAGNOSTICS, LLC Topic: 300DESCRIPTION Glycans have several distinct properties that make them excellent targets for disease biomarkers Firstly the location of the glycans on the cell surface makes them the first point of contact of cellular interactions and thus crucial in the control of normal metabolic processes Cell surface molecules are also strategically exposed for surveillance by the immune system allowing for ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Phase II SBIR: Responding to NDM-1- Advancement of a new MBL inhibitor to IND
SBC: VENATORX PHARMACEUTICALS INC Topic: NIAIDDESCRIPTION provided by applicant Multi drug resistance in Enterobacteriaceae is regarded as a healthcare crisis While carbapenems are among the most prescribed antibiotics for infections caused by these organisms carbapenem resistance conferred by zinc based metallo carbapenemases Amber Class B is a growing global health concern that threatens to erode the efficacy of these antibiotics both in th ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Preserving beta-lactam utility vs pathogens producing any class of beta-lactamase
SBC: VENATORX PHARMACEUTICALS INC Topic: NIAIDDESCRIPTION provided by applicant Multi drug resistance in Enterobacteriaceae is regarded as a healthcare crisis This crisis has been further amplified by the recent emergence of the NDM andquot super bug geneandquot a zinc based metallo lactamase Amber Class B in Enterobacteriaceae Members of this family of resistance enzymes are found on promiscuous plasmids with other MDR resistance mechanisms ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of a Urine Test for the Early Detection of Liver Cancer
SBC: JBS SCIENCE INC Topic: NCIDESCRIPTION provided by applicant Development of a urine test for the early detection of liver cancer The need to develop an effective method of detecting hepatocellular carcinoma HCC is urgent HCC is the third leading cause of cancer deaths and has a year survival rate of less than If HCC is identified early the survival rate can be as high as The survival rate drops significantly however to as l ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
A new radiopharmaceutical for the treatment of metastatic bone cancer
SBC: IsoTherapeutics Group LLC Topic: NCIDESCRIPTION provided by applicant There are roughly new cases of metastatic cancer to the skeleton in the U S each year andquot Bone seekingandquot radiopharmaceuticals are used for bone pain palliation and have shown promise for treating bone metastases They typically combine a radioactive metal such as samarium with a chelant The chelant part of the molecule is taken up by gr ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Stimulating Young Neuroscientists And Physiologists in Science Education- Phase
SBC: IS3D LLC Topic: 101DESCRIPTION provided by applicant This project will develop a suite of innovative learning experiences that will engage high school students in neuroscience and thereby increase their interest in possible careers in this area This will be achieved by creating highly interactive and immersive products developed in partnership with neuroscience experts science teachers and science education re ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
An Automated Platform for High-throughput Network Electrophysiology
SBC: Axion Biosystems, Inc. Topic: 102DESCRIPTION provided by applicant In response to the program announcement for Phase IIb proposals for complex in vitro brain and behavior tools PA this proposed study automates all aspects of in vitro Microelectrode Array MEA technology to deliver the first ever high throughput MEA based screening system This development will not only enable rapid advancements in the study of basi ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Biomarker Quantitation by NP-MS Tissue Imaging.
SBC: IONWERKS INC Topic: NIDADESCRIPTION provided by applicant MALDI tissue imaging when enabled by Nanoparticulate NP Matrix implantation is maturing into a useful preclinical tool for biomarker and drug discovery in our laboratory and at NIDA IRP Quantitatively reproducible images from serial coronal sections suggest that relative quantitation is now possible in rodent models of disease and injury Nanoparticulate ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Long-Acting G-CSF Analog for Treating ARS
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of Inhaled Vancomycin for Treatment of MRSA Infections in CF
SBC: SAVARA INC. Topic: NHLBIDESCRIPTION provided by applicant Persistent respiratory methicillin resistant Staphylococcus aureus MRSA infections have become increasingly common in cystic fibrosis CF patients with a prevalence of almost in CF patients in the US This is concerning as MRSA positivity is associated with a faster decline of lung function and a years shorter median life expectancy compared to CF p ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health